OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 49 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$291,000,000493,5970.01%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
NEA Management Company, LLC 25,243,865$21,318,0001.76%
X-Square Capital, LLC 652,605$551,0000.35%
683 Capital Management, LLC 1,978,723$1,671,0000.19%
WealthTrust Axiom LLC 138,085$116,0000.04%
EXCALIBUR MANAGEMENT CORP 51,000$43,0000.04%
Caption Management, LLC 748,200$632,0000.03%
GSA CAPITAL PARTNERS LLP 125,346$106,0000.01%
Larson Financial Group LLC 26,475$22,0000.01%
Virtu Financial LLC 164,673$139,0000.01%
Evercore Wealth Management, LLC 418,414$353,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders